Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Immunoglobulins Market Size to Reach Revenues of USD 21.58 Billion by 2026 - Arizton

This image opens in the lightbox

News provided by

Arizton Advisory & Intelligence

13 Sep, 2021, 19:00 GMT

Share this article

Share toX

Share this article

Share toX

In-depth analysis and data-driven insights on the impact of COVID-19 included in this global immunoglobulin market report.

CHICAGO, Sept. 13, 2021 /PRNewswire/ -- The immunoglobulins market is expected to grow at a CAGR of 8.01% during the period 2020−2026.

Key Highlights Offered in the Report:  

  • Immunoglobulins market holds major share in the targeted protein therapeutics market. 
  • Developments in plasma fractionation process and recent regulatory approvals are expected to boost the market during the forecast period.
  • In product type, IVIG holds major market share of around 82.20%, however SCIG is expected to grow with fastest CAGR of 11.11%.
  • PID holds major share and is expected to dominate the market during with forecast period with an incremental growth of USD 1.85 billion.
  • Due to the shifting preferences from hospital to home administration in end user segment homecare is anticipated to be the fastest growing segment with an incremental growth of USD 2.13 billion and a CAGR of 10.05%.
  • North America region is dominating the global immunoglobulins market and is likely to witness highest incremental growth of USD 3.03 billion and APAC is expected to witness highest absolute growth of over 79.35% during the forecast period.

Key Offerings:

  • Market Size & Forecast by Revenue | 2020−2026
  • Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
  • Market Segmentation – A detailed analysis by products type, application, end-user, and geography
  • Competitive Landscape – 5 key vendors and 8 other vendors

Get your sample today! https://www.arizton.com/market-reports/immunoglobulins-market-size 

Immunoglobulins Market – Segmentation

  • Intravenous immunoglobulins or IVIG is the most used form of immunoglobulin for the management of autoimmune diseases and immunodeficiency. The global intravenous immunoglobulins market is expected to reach USD 17.05 billion by 2026.
  • With the growing developments in the global immunoglobulins market, the intramuscular immunoglobulins segment is expected to witness several new entrants, thereby boosting the market growth.
  • Western regions such as North America, Latin America, and Western Europe witnessed the highest prevalence of primary immunodeficiency. The global primary immunodeficiency immunoglobulins market growing at a CAGR of 7.26% during the period.
  • In 2020, the global hospitals and clinics immunoglobulins market was valued at USD 10.85. The hospitals and clinics segment includes the revenue generated from immunoglobulin formulations in hospital, clinic, and inpatient settings. The global hospitals and clinics immunoglobulins market was valued at USD 10.85 billion.

Immunoglobulins Market Segmentation by Products Type

  • Intravenous Immunoglobulin
  • Subcutaneous Immunoglobulin
  • Intramuscular Immunoglobulin

Immunoglobulins Market Segmentation by Application

  • Primary Immunodeficiency
  • Chronic Immune Deficiency Polyradiculoneuropathy
  • Secondary Immunodeficiency
  • Immune Thrombocytopenic Purpura
  • Myasthenia Gravis
  • Others

Immunoglobulins Market Segmentation by End-User

  • Hospitals & Clinics
  • Homecare

Immunoglobulins Market – Dynamics

The immunoglobulins market is growing at a rapid rate due to the increasing prevalence of autoimmune diseases cases and the development in diagnosing technologies. Partnerships with official plasma collection agencies have propelled the growth of many vendors. Many new vendors entering to the market have benefitted from such partnerships. Increasing development of new launches and approvals for immunoglobulins beyond PIDs are expected to fuel the growth of the immunoglobulins market during the forecast period. With the increasing demand for immunoglobulin products across the globe, the plasma fractionation industry is looking for such methods that will offer improved productivity and IgG recovery while keeping wastage at a minimum.

Key Drivers and Trends fueling Market Growth:

  • Developments in Plasma Fractionation Process
  • Rising Adoption of Immunoglobulins in Homecare
  • High Usage of IVIG During Transplant
  • Self-Sufficiency Programs for Plasma-Derived Medicinal Products

Immunoglobulins Market – Geography

North America has been leading the plasma-derived medicinal products market that includes products such as immunoglobulins and albumins. The US and Canada both have the highest volume of consumption of IVIG products. Immunoglobulins market in North America is a mature market. The US provides almost 71% of the global source plasma, which is much higher than any country across the globe. In 2020, US was a leading country in the global immunoglobulins market, with a 41.50% market share across the region. The immunoglobulins market in the US will grow at a CAGR of 6.84% in the upcoming years.

Get your sample today! https://www.arizton.com/market-reports/immunoglobulins-market-size

Immunoglobulins Market by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey

Major Vendors

  • Takeda Pharmaceutical Company Limited
  • CSL Limited
  • Grifols, S.A.
  • Kendrion Biopharma
  • Octapharma AG

Other Prominent Vendors

  • China Biologic Products Holdings, Inc.
  • Biotest AG
  • LFB S.A
  • ADMA Biologics, Inc.
  • Omrix Biopharmaceuticals LTD
  • Zydus Cadila
  • Bharat Serums and Vaccines Limited
  • Reliance Life Sciences

Explore our healthcare & lifesciences profile to know more about the industry.

Read some of the top-selling reports:

  • Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026
  • Oral Antiseptics Market - Global Outlook & Forecast 2021-2026
  • Medication Management Market - Global Outlook & Forecast 2021-2026
  • Allergy Treatment Market - Global Outlook & Forecast 2021-2026

About Arizton:

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Mail: enquiry@arizton.com

Call: +1-312-235-2040 
         +1 302 469 0707

Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.